Stereotaxis Announces Partnership with Kansas City Heart Rhythm Institute to Bring New Treatment to Arrhythmia Patients Read more about Stereotaxis Announces Partnership with Kansas City Heart Rhythm Institute to Bring New Treatment to Arrhythmia Patients
Stereotaxis to Present at the 11th Annual LD Micro Main Event Investor Conference Read more about Stereotaxis to Present at the 11th Annual LD Micro Main Event Investor Conference
Stereotaxis Reports 2018 Third Quarter Financial Results Read more about Stereotaxis Reports 2018 Third Quarter Financial Results
Stereotaxis to Report Third Quarter 2018 Financial Results on November 12, 2018 Read more about Stereotaxis to Report Third Quarter 2018 Financial Results on November 12, 2018
Stereotaxis to Present at OTCQX Virtual Investor Conference for Domestic Companies Read more about Stereotaxis to Present at OTCQX Virtual Investor Conference for Domestic Companies
Stereotaxis Reports 2018 Second Quarter Financial Results Read more about Stereotaxis Reports 2018 Second Quarter Financial Results
Stereotaxis to Report Second Quarter 2018 Financial Results on August 7, 2018 Read more about Stereotaxis to Report Second Quarter 2018 Financial Results on August 7, 2018
Stereotaxis and Johnson & Johnson’s Biosense Webster Extend Development Alliance and Supply Agreement Read more about Stereotaxis and Johnson & Johnson’s Biosense Webster Extend Development Alliance and Supply Agreement
Stereotaxis Announces Changes to its Board of Directors Read more about Stereotaxis Announces Changes to its Board of Directors
Stereotaxis to Present at 8th Annual LD Micro Invitational Read more about Stereotaxis to Present at 8th Annual LD Micro Invitational